mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.09 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.1 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.1 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.1 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.1 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.1 |